Werner Sean
Transaction: 07/17/2026
SELL
Change
-275
Price
$29.15
Filing
07/21/2026
Type
SELL
BioLife Solutions, Inc.
BLFS • Medical - Instruments & Supplies
$35.25
▼ -0.28 (-0.79%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$1.74B
Growth
10.4%
Cash Flow
2/5
Trend
Volatile
Evidence
Positive free cash flow · 0.22Manageable debt level · 0.05Healthy liquidity · 5.94Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:10 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$35.25
Change-0.79%
Shares Out49.29M
Market Cap$1.74B
Enterprise Value$1.66B
52W Range17.86 - 34.32
Beta1.94
P/E34.45
P/S16.90
P/B4.14
P/FCF233.27
EV/Sales16.10
Price$35.25
Change-0.79%
Shares Out49.29M
Market Cap$1.74B
Enterprise Value$1.66B
52W Range17.86 - 34.32
Beta1.94
P/E34.45
P/S16.90
P/B4.14
P/FCF233.27
EV/Sales16.10
EV/EBITDA169.21
EV/FCF222.21
Earnings Yield2.90%
FCF Yield0.43%
Dividend Yield0.00%
Gross Margin64.56%
Oper. Margin-12.61%
Profit Margin-12.61%
Debt/Eq0.05
Current Ratio5.94
Quick Ratio4.63
Revenue 5Y10.45%
Target$31.00
Target Upside-12.06%
Target Median$31.00
Target Range31.00 - 31.00
Volume461.48K
Avg Volume1.03M
EPS Surprise0.03
Investment DNA
How strong this company looks for long-term investors
42
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
58/100
Price Attractiveness
Cheap or expensive today
39/100
Why this score▼
Positive free cash flow · 0.22Manageable debt level · 0.05Healthy liquidity · 5.94Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 18 analyst votes · 2026-09-04
83/100
Bullish
Bullish
12
Hold
6
Bearish
0
Price Target
2026-08-07
Low
$31.00
Mean
$31.00
Median
$31.00
High
$31.00
Insider Transactions
Recent executive and insider activity
⚠ 3 high-volume insider sells detected
Berard Todd
Transaction: 07/07/2026
SELL
Change
-293
Price
$27.79
Filing
07/13/2026
Type
SELL
Mathew Aby J.
Transaction: 07/07/2026
SELL
Change
-516
Price
$27.79
Filing
07/13/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Werner Sean | SELL | -275 | $29.15 | 07/17/2026 | 07/21/2026 |
| Berard Todd | SELL | -293 | $27.79 | 07/07/2026 | 07/13/2026 |
| Mathew Aby J. | SELL | -516 | $27.79 | 07/07/2026 | 07/13/2026 |
| Wichterman Troy | SELL | -844 | $27.79 | 07/07/2026 | 07/13/2026 |
| Mathew Aby J. | SELL | -564 | $26.04 | 06/18/2026 | 06/22/2026 |
| Wichterman Troy | SELL | -937 | $26.04 | 06/18/2026 | 06/22/2026 |
| DE GREEF RODERICK | SELL | -2,775 | $26.04 | 06/18/2026 | 06/22/2026 |
| Werner Sean | SELL | -420 | $26.04 | 06/18/2026 | 06/22/2026 |
| Berard Todd | SELL | -470 | $26.04 | 06/18/2026 | 06/22/2026 |
| Mathew Aby J. | SELL | -627 | $26.10 | 06/08/2026 | 06/10/2026 |
| Berard Todd | SELL | -356 | $26.10 | 06/08/2026 | 06/10/2026 |
| Wichterman Troy | SELL | -1,026 | $26.10 | 06/08/2026 | 06/10/2026 |
| Casdin Partners Master Fund, L.P. | SELL | -650,000 | $23.70 | 05/21/2026 | 05/21/2026 |
| Casdin Partners Master Fund, L.P. | SELL | -250,000 | $23.70 | 05/20/2026 | 05/21/2026 |
| Casdin Partners Master Fund, L.P. | SELL | -300,000 | $22.65 | 05/19/2026 | 05/21/2026 |
| Wichterman Troy | SELL | -844 | $19.27 | 04/08/2026 | 04/10/2026 |
| Berard Todd | SELL | -293 | $19.27 | 04/08/2026 | 04/10/2026 |
| Mathew Aby J. | SELL | -515 | $19.27 | 04/08/2026 | 04/10/2026 |
| Foster Karen A. | SELL | -2,577 | $19.17 | 03/23/2026 | 03/31/2026 |
| Mathew Aby J. | SELL | -2,255 | $19.12 | 03/19/2026 | 03/23/2026 |